3
Announcements
Trials
Browse
Landscape
Sponsor
Cancer Type
Gastrointestinal
64
Lymphoid
8
Other solid neoplasm
4
Thoracic
3
Gynecologic
3
Tumor-Agnostic
2
Sarcoma
2
CNS
2
Other hematologic neoplasm
1
Head & Neck
1
Genitourinary
1
Dermatologic
1
Breast
1
Interventions
Specimen Handling
10
Magnetic Resonance Spectroscopy
10
lutetium Lu 177 dotatate
8
cabozantinib
4
Nivolumab
4
Cisplatin
4
pembrolizumab
3
X-Rays
3
Ipilimumab
3
Everolimus
3
Etoposide
3
Carboplatin
3
olaparib
2
gallium Ga 68 dotatate
2
fluorodopa F 18
2
fludarabine
2
aldesleukin
2
Phantoms, Imaging
2
Lutetium-177
2
Lutetium
2
Irinotecan
2
Fluorodeoxyglucose F18
2
Cyclophosphamide
2
CTLA-4 Antigen
2
trametinib
1
tipifarnib
1
sodium thiosulfate
1
selpercatinib
1
repotrectinib
1
peposertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Oxaliplatin
×
Endocrine
×
30 days
×
Clear all
No trials found.